Tumours need a blood supply to grow and so it make sense to hypothesise that if the growth of blood vessels in tumors could be stopped, the tumour would effectively die.
Enter a group of antibodeis that can be used to destroy the protein (vascular endothelial growth factor or VEGF) that tells the blood vessels to divide.




